- Rank in Search Criteria: 6231
World Rank (Jan-05-2024): 10,849
Market Cap (Jan-05-2024): 0.67 Billion USD
World Rank (Jul-30-2023): 12893
Market Cap (Jul-30-2023): 0.49 Billion USD
World Rank (Jan-2022): 13,491
Market Cap (Jan-2022): 0.50 Billion USD
- Rank in Search Criteria: 6232
World Rank (Jan-05-2024): 10,850
Market Cap (Jan-05-2024): 0.67 Billion USD
World Rank (Jul-30-2023): 10180
Market Cap (Jul-30-2023): 0.77 Billion USD
World Rank (Jan-2022): 9,488
Market Cap (Jan-2022): 0.99 Billion USDHeadquarters Country: China
- Rank in Search Criteria: 6233
World Rank (Jan-05-2024): 10,851
Market Cap (Jan-05-2024): 0.67 Billion USD
World Rank (Jul-30-2023): 11180
Market Cap (Jul-30-2023): 0.64 Billion USD
World Rank (Jan-2022): 8,458
Market Cap (Jan-2022): 1.21 Billion USDHeadquarters Country: China
- Rank in Search Criteria: 6234
World Rank (Jan-05-2024): 10,852
Market Cap (Jan-05-2024): 0.67 Billion USD
World Rank (Jul-30-2023): 10169
Market Cap (Jul-30-2023): 0.77 Billion USD
Headquarters Country: China
- Rank in Search Criteria: 6235
World Rank (Jan-05-2024): 10,853
World Rank (Jul-30-2023): 10853
Market Cap (Jul-30-2023): 0.68 Billion USD
World Rank (Jan-2022): 12,533
Market Cap (Jan-2022): 0.58 Billion USDAnnual Revenue in USD: 334 Million USD
Annual Net Income in USD: 44 Million USD
Annual Results for Period ending: Dec-2021 ending year
- Rank in Search Criteria: 6236
World Rank (Jan-05-2024): 10,853
Market Cap (Jan-05-2024): 0.67 Billion USD
World Rank (Jul-30-2023): 9963
Market Cap (Jul-30-2023): 0.79 Billion USD
World Rank (Jan-2022): 8,762
Market Cap (Jan-2022): 1.14 Billion USDCompany Profile: Gongwin Biopharm Holdings is a clinical stage biopharmaceutical company focused on developing novel anti-cancer drugs. The headquarters is in Taiwan.
- Rank in Search Criteria: 6237
World Rank (Jan-05-2024): 10,854
Market Cap (Jan-05-2024): 0.67 Billion USD
World Rank (Jul-30-2023): 10440
Market Cap (Jul-30-2023): 0.73 Billion USD
World Rank (Jan-2022): 12,812
Market Cap (Jan-2022): 0.56 Billion USDHeadquarters Country: India Annual Revenue in USD: 124 Million USD
Annual Net Income in USD: 14 Million USD
Annual Results for Period ending: Jun-2022 ending year
- Rank in Search Criteria: 6238
World Rank (Jan-05-2024): 10,855
Market Cap (Jan-05-2024): 0.67 Billion USD
World Rank (Jul-30-2023): 12894
Market Cap (Jul-30-2023): 0.49 Billion USD
World Rank (Jan-2022): 10,172
Market Cap (Jan-2022): 0.87 Billion USD
- Rank in Search Criteria: 6239
World Rank (Jan-05-2024): 10,858
Market Cap (Jan-05-2024): 0.67 Billion USD
World Rank (Jul-30-2023): 10562
Market Cap (Jul-30-2023): 0.72 Billion USD
World Rank (Jan-2022): 11,856
Market Cap (Jan-2022): 0.65 Billion USD
- Rank in Search Criteria: 6240
World Rank (Jan-05-2024): 10,859
Market Cap (Jan-05-2024): 0.67 Billion USD
World Rank (Jul-30-2023): 10950
Market Cap (Jul-30-2023): 0.67 Billion USD
World Rank (Jan-2022): 10,423
Market Cap (Jan-2022): 0.84 Billion USDHeadquarters Country: China